25.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Zenas Biopharma Inc-Aktie (ZBIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.00
|
- | - | - | - |
| Operating Expenses |
40.48%
108.66
|
77.35 | 237.98 | 52.58 | 55.16 |
| Operating Income/Loss |
39.18%
-107.66
|
-77.35 | -237.98 | -52.58 | -55.16 |
| Nonoperating Income/Loss |
1.26%
-3.683
|
-3.637 | -2.352 | 1.081 | 2.96 |
| Income/Loss From Continuing Operations Before Tax |
37.48%
-111.34
|
-80.99 | -240.34 | -51.50 | -52.20 |
| Income Tax Expense/Benefit |
0.114
|
- | 0.106 | - | 0.02 |
| Net Income/Loss |
37.62%
-111.46
|
-80.99 | -240.44 | -51.50 | -52.22 |
| Basic Average Shares |
13.46%
63.11
|
55.62 | - | 42.16 | 41.87 |
| Diluted Average Shares |
13.46%
63.11
|
55.62 | - | 42.16 | 41.87 |
| Basic Earnings Per Share |
21.23%
-1.77
|
-1.46 | - | -1.22 | -1.25 |
| Diluted Earnings Per Share |
21.23%
-1.77
|
-1.46 | - | -1.22 | -1.25 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):